Cargando…
RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates
Amber codon suppression for the insertion of non-natural amino acids (nnAAs) is limited by competition with release factor 1 (RF1). Here we describe the genome engineering of a RF1 mutant strain that enhances suppression efficiency during cell-free protein synthesis, without significantly impacting...
Autores principales: | Yin, Gang, Stephenson, Heather T., Yang, Junhao, Li, Xiaofan, Armstrong, Stephanie M., Heibeck, Tyler H., Tran, Cuong, Masikat, Mary Rose, Zhou, Sihong, Stafford, Ryan L., Yam, Alice Y., Lee, John, Steiner, Alexander R., Gill, Avinash, Penta, Kalyani, Pollitt, Sonia, Baliga, Ramesh, Murray, Christopher J., Thanos, Christopher D., McEvoy, Leslie M., Sato, Aaron K., Hallam, Trevor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465077/ https://www.ncbi.nlm.nih.gov/pubmed/28596531 http://dx.doi.org/10.1038/s41598-017-03192-z |
Ejemplares similares
-
In vitro Fab display: a cell-free system for IgG discovery
por: Stafford, Ryan L., et al.
Publicado: (2014) -
Methods to Make Homogenous Antibody Drug Conjugates
por: Kline, Toni, et al.
Publicado: (2014) -
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
por: Li, Xiaofan, et al.
Publicado: (2023) -
Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
por: Xu, Yiren, et al.
Publicado: (2014) -
An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates
por: Hanson, Jeffrey, et al.
Publicado: (2023)